Trial Profile

Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure (CONNECT-HF)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 04 May 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sacubitril/valsartan (Primary)
Indications Heart failure
Focus Therapeutic Use
Acronyms CONNECT-HF

Most Recent Events

06 Mar 2023 Results (n=4646 patients enrolled between 2017-2020) assessing to describe patterns of adjustment of GDMT one year post-HF hospitalization and patterns of post-discharge medication changes during follow-up, presented at the 72nd Annual Scientific Session of the American College of Cardiology together with the World Heart Federation.
07 Sep 2021 According to Heart Failure Society of America (HFSA) media release, HFSA will host two late breaking clinical trials sessions which includes data from this trial in Annual Scientific Meeting (ASM) 2021
22 Jan 2021 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com